David Mehalick Coeptis Therapeutics Inc. (COEP) insider trading activity

COEP Quotes by TradingView

David Mehalick is CEO and President of Coeptis Therapeutics Inc.. Currently has a direct ownership of 1.8 Million shares of COEP, which is worth approximately $504,000. The most recent transaction as insider was on Nov 16, 2021, when has been sold 1,200,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.8M
0% 3M change
0% 12M change
Total Value Held $504,000

David Mehalick Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 16 2021
SELL
Open market or private sale
-
1,200,000 Reduced 40.0%
1,800,000 Common Stock

Also insider at

BHSEU
Bull Horn Holdings Corp. Financial Services
CEO and President
DM

David Mehalick

CEO and President
Wexford, PA

Track Institutional and Insider Activities on COEP

Follow Coeptis Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells COEP shares.

Notify only if

Insider Trading

Get notified when an Coeptis Therapeutics Inc. insider buys or sells COEP shares.

Notify only if

News

Receive news related to Coeptis Therapeutics Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on COEP